HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedEUCTR 2009-015538-30

Effect of intranasal oxytocin on social approach in patients with social phobia and healthy control

This historical record does not confirm current site availability.

Historical research recordGermanyMental health
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Germany
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
Rheinisch-Westfälisch Technische Hochschule Aachen
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany
Age range
Not clearly listed
Official registry ID
EUCTR 2009-015538-30
Official title
Show the full official title

Effect of intranasal oxytocin on social approach in patients with social phobia and healthy control

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Germany

Checked Official study record (opens in a new tab)
Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Rheinisch-Westfälisch Technische Hochschule Aachen.

Want to explore more studies?

Explore studies